Active	Status	Sponsor type	Region	Phase	Filter
10 Active 4 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hettmer, Simone
CAMPFIRE, NCT05999994: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer	Recruiting	2	105	Europe, Japan, US, RoW	Ramucirumab, LY3009806, Cyclophosphamide, Vinorelbine, Gemcitabine, LY188011, Docetaxel, Abemaciclib, LY2835219, Irinotecan, Temozolomide	Eli Lilly and Company	Neoplasms, Child, Adolescent	05/27	05/27
NCT05440786 / 2021-004734-11: CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma	Recruiting	2	45	Europe, Japan, US, RoW	Abemaciclib, LY2835219, Irinotecan, Temozolomide	Eli Lilly and Company	Sarcoma, Ewing, Neoplasm Metastasis	02/27	09/28